Loring Wolcott & Coolidge Fiduciary Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.63K Sell
268
-425
-61% -$5.08K ﹤0.01% 550
2026
Q1
$6.12K Hold
693
﹤0.01% 533
2025
Q4
$6.24K Sell
693
-509
-42% -$4.02K ﹤0.01% 509
2025
Q3
$10.9K Sell
1,202
-224
-16% -$2.2K ﹤0.01% 502
2025
Q2
$13.8K Sell
1,426
-1
-0.1% -$10 ﹤0.01% 468
2025
Q1
$16.4K Hold
1,427
﹤0.01% 456
2024
Q4
$23.2K Sell
1,427
-1
-0.1% -$16 ﹤0.01% 444
2024
Q3
$24.6K Sell
1,428
-332
-19% -$6.88K ﹤0.01% 447
2024
Q2
$36.6K Buy
1,760
+12
+0.7% +$238 ﹤0.01% 420
2024
Q1
$31.5K Sell
1,748
-251
-13% -$4.31K ﹤0.01% 429
2023
Q4
$33.3K Sell
1,999
-539
-21% -$7.33K ﹤0.01% 429
2023
Q3
$33.3K Hold
2,538
﹤0.01% 450
2023
Q2
$52.8K Sell
2,538
-270
-10% -$5.87K ﹤0.01% 420
2023
Q1
$66K Sell
2,808
-125
-4% -$3.36K ﹤0.01% 381
2022
Q4
$81.9K Sell
2,933
-99
-3% -$2.53K ﹤0.01% 362
2022
Q3
$71K Sell
3,032
-480
-14% -$14.5K ﹤0.01% 378
2022
Q2
$119K Sell
3,512
-1,536
-30% -$53.8K ﹤0.01% 341
2022
Q1
$176K Sell
5,048
-656
-12% -$22.4K ﹤0.01% 315
2021
Q4
$174K Sell
5,704
-2,262
-28% -$73.7K ﹤0.01% 329
2021
Q3
$261K Sell
7,966
-10,303
-56% -$330K ﹤0.01% 275
2021
Q2
$553K Buy
+18,269
New +$601K 0.01% 215

Other funds holding OGN

Loring Wolcott & Coolidge Fiduciary Advisors's OGN Position: Q2 2026 in Review

Loring Wolcott & Coolidge Fiduciary Advisors reduced its Organon & Co (OGN) stake by 61% in Q2 2026, selling an estimated $5.08K and leaving 268 shares worth $3.63K. The position accounts for ﹤0.01% of the portfolio, ranked #550.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $553K in Q2 2021. 438 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Loring Wolcott & Coolidge Fiduciary Advisors held 268 shares of Organon & Co worth $3.63K as of Q2 2026.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 425 Organon & Co shares in Q2 2026, an estimated $5.08K.
  • Organon & Co made up ﹤0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #550 holding.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Organon & Co position peaked at $553K in Q2 2021.
  • 438 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.